Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intravitreal Injection”

592 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 592 results

Post-approval studies (Phase 4)Study completedNCT02953938
What this trial is testing

Study to Show a Superior Benefit in Terms of Reduction of Ranibizumab Injections in Patients Receiving Ranibizumab Plus Laser Photocoagulation Combination Therapy Without Loss of Efficacy and Safety

Who this might be right for
Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO)
Novartis Pharmaceuticals 59
Post-approval studies (Phase 4)Study completedNCT00557232
What this trial is testing

Intraocular Bevacizumab (Avastin) for Rubeosis Iridis

Who this might be right for
GlaucomaRubeosis Iridis
Instituto de Olhos de Goiania 25
Not applicableUnknownNCT01303276
What this trial is testing

Retinal Blood Flow in Response to an Intravitreal Injection of Ranibizumab for Central Retinal Vein Occlusion (CRVO)

Who this might be right for
Central Retinal Vein Occlusion
University of Toronto 30
Post-approval studies (Phase 4)Study completedNCT02392364
What this trial is testing

Variable Interval Versus Set Interval Aflibercept for DME

Who this might be right for
Cystoid Macular EdemaDiabetic Macular Edema
California Retina Consultants 50
Testing effectiveness (Phase 2)UnknownNCT01178697
What this trial is testing

Intravitreal Bevasizumab Versus Intravitreal Triamcinolone in Central Retinal Vein Occlusion (CRVO)

Who this might be right for
Central Retinal Vein Occlusion
Shahid Beheshti University of Medical Sciences
Early research (Phase 1)Study completedNCT02280135
What this trial is testing

Clinical Trial of Intravitreal Injection of Autologous Bone Marrow Stem Cells in Patients With Retinitis Pigmentosa

Who this might be right for
Retinitis Pigmentosa
Red de Terapia Celular 8
Large-scale testing (Phase 3)Study completedNCT00344968
What this trial is testing

Fluocinolone Acetonide Implant Compared to Sham Injection in Patients With Diabetic Macular Edema

Who this might be right for
Diabetic Macular Edema
Alimera Sciences 956
Not applicableEnrolling By InvitationNCT05921162
What this trial is testing

A Long-Term Follow-Up Study in Subjects Who Received vMCO-I Administered Via Intravitreal Injection

Who this might be right for
Retinitis PigmentosaRetinal DiseaseRetinal Degeneration
Nanoscope Therapeutics Inc. 11
Not applicableStudy completedNCT03509623
What this trial is testing

Blood Coagulation Parameters in Patients Receiving Intravitreal Aflibercept for Age-related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
University Hospital of Patras 47
Testing effectiveness (Phase 2)Ended earlyNCT00114062
What this trial is testing

Study to Treat Uveitis Associated Macular Edema

Who this might be right for
Cystoid Macular EdemaUveitis
Merck Sharp & Dohme LLC 15
Large-scale testing (Phase 3)Study completedNCT02652767
What this trial is testing

Efficacy Study of GS010 for the Treatment of Vision Loss up to 6 Months From Onset in LHON Due to the ND4 Mutation

Who this might be right for
Optic, Atrophy, Hereditary, Leber
GenSight Biologics 39
Not applicableStudy completedNCT04008771
What this trial is testing

Intravitreal Injection of SeeQ CdSe 655 Alt Nanoparticles for Patients With Degenerative Retinal Diseases

Who this might be right for
Retinitis Pigmentosa
2C Tech Corp 20
Testing effectiveness (Phase 2)UnknownNCT01123564
What this trial is testing

Efficacy and Safety of Lucentis for Clinically Significant Macular Edema Secondary to Central Retinal Vein Occlusion

Who this might be right for
Retinal Vein OcclusionMacular Edema
University of Pecs 40
Testing effectiveness (Phase 2)Ended earlyNCT01025232
What this trial is testing

Intravitreal Injections of 2.0mg Ranibizumab in Subjects With Chronic Fluid On OCT Post Multiple Injections With Ranibizumab (Super-dose Anti-VEgf SAVE Trial)

Who this might be right for
Age Related Macular DegenerationChoroidal Neovascular MembraneSubfoveal Neovascular Age-Related Macular Degeneration+2 more
David M. Brown, M.D. 88
Post-approval studies (Phase 4)UnknownNCT01486771
What this trial is testing

Macugen for Proliferative Diabetic Retinopathy Study With Extended Dosing (M-PDRS ED)

Who this might be right for
Proliferative Diabetic Retinopathy
Valley Retina Institute 30
Large-scale testing (Phase 3)Study completedNCT00105404
What this trial is testing

Treatment of Diabetic Macular Edema: Triamcinolone Injections Vs. Laser Photocoagulation

Who this might be right for
Diabetic RetinopathyDiabetic Macular EdemaDME
National Eye Institute (NEI) 5
Large-scale testing (Phase 3)WithdrawnNCT03784443
What this trial is testing

Combined Ranibizumab and Iluvien for Diabetic Macular Oedema

Who this might be right for
Diabetic Macular EdemaDiabetes
Imperial College London
Large-scale testing (Phase 3)Study completedNCT04278417
What this trial is testing

Study of Efficacy and Safety of Brolucizumab Versus Panretinal Photocoagulation Laser in Patients With Proliferative Diabetic Retinopathy

Who this might be right for
Proliferative Diabetic Retinopathy
Novartis Pharmaceuticals 689
Not applicableStudy completedNCT02121197
What this trial is testing

Retrospective Trial on the Efficacy and Safety of Intravitreal Ozurdex in Patients With Diabetic Macular Edema.

Who this might be right for
Diabetic Macular Edema
Association for Innovation and Biomedical Research on Light and Image 321
Post-approval studies (Phase 4)Study completedNCT01871376
What this trial is testing

Intravitreal Aflibercept Injection for Polypoidal Choroidal Vasculopathy With Hemorrhage or Exudation

Who this might be right for
Polypoidal Choroidal Vasculopathy
Gregg T. Kokame, MD 25
Load More Results